Synthes, Globus call truce on trade secrets dispute
This article was originally published in Clinica
Swiss spinal implant developer Synthes, which has its US headquarters based in West Chester, Pennsylvania, is to gain $13.5m from rival Globus Medical to settle a row over the alledged theft of trade secrets as well as violations of non-compete and confidentiality agreements. Under the terms of the settlement, Audubon, Pennsylvania-based Globus, which continues to maintain it has not taken any trade secrets, also agreed to not solicit or hire Synthes employees for one year until August 10 2008. In return, Synthes has dropped all six lawsuits filed against Globus.
You may also be interested in...
Pain relief product sales grew 27% and upper respiratory sales 35% for the week ended 7 March as consumers respond to COVID-19, according to Nielsen data noted in a Jefferies report on consumer health purchasing trends. Private label market share is up slightly, while OTC purchases continue primarily in conventional stores.
Managing partner Corey Goodman said venBio didn’t have trouble closing its fund, because the venture capital firm prepared its investors for an economic downturn months ago.
The US FDA has proposed moving two categories of hepatitis C diagnostics to class II from class III because they pose relatively low risk.